<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-987
Date of Submission: 2024-08-31

This report was submitted by a Other Healthcare Professional from Cox, Edwards and Watson Medical Center concerning patient ANON-PX-3810. The subject is a 63-year-old female with a significant medical history including hypertension, seasonal allergies, chronic kidney disease. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Sertraline administered via the Intravenous route at a dosage of 439mg, initiated on 2024-07-08 for Major depressive disorder with the course ongoing.

On approximately 2024-08-11, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Headache, Stevens-Johnson syndrome. The Headache was classified as Life-threatening in severity. This necessitated clinical intervention. The documented action was: Prescribed market and advised measure. The current patient status regarding this symptom is 'Unknown'. The Stevens-Johnson syndrome was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Positive dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Successful ahead already current. Population represent front back decide right man. Audience expect kind seem not.</data>
report_id: ADR-2024-987
report_date: '2024-08-31'
patient_details:
  patient_id: ANON-PX-3810
  gender: Female
  relevant_history:
  - hypertension
  - seasonal allergies
  - chronic kidney disease
  age_at_reaction: 63
suspected_drugs:
- drug_name: Sertraline
  dosage: 439mg
  route_of_administration: Intravenous
  start_date: '2024-07-08'
  indication_for_use: Major depressive disorder
adverse_reactions:
- symptom_name: Headache
  onset_date: '2024-08-11'
  severity: Life-threatening
  outcome: Unknown
  intervention_required: true
  intervention_details: Prescribed market and advised measure.
- symptom_name: Stevens-Johnson syndrome
  onset_date: '2024-08-11'
  severity: Mild
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Positive dechallenge
reporting_facility: Cox, Edwards and Watson Medical Center
reporter_type: Other Healthcare Professional
notes: Successful ahead already current. Population represent front back decide right
  man. Audience expect kind seem not.
